狼疮-话题@MedSci

#狼疮#

495篇内容 | 6845人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1387368, encodeId=7bdc138e368fc, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=葛兰素史克的狼疮药物Benlysta在欧洲获得适应症扩容, objectType=article, longId=182190, objectId=e74d182190ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e74d182190ad, replyNumber=0, likeNumber=69, createdTime=2019-11-01, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e74d182190ad, moduleTitle=葛兰素史克的狼疮药物Benlysta在欧洲获得适应症扩容, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e74d182190ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387367, encodeId=e194138e36775, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=狼疮性肾炎：已启动Itolizumab治疗狼疮性肾炎的Ib期临床试验, objectType=article, longId=180389, objectId=f1d1180389f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1d1180389f8, replyNumber=0, likeNumber=55, createdTime=2019-10-04, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1d1180389f8, moduleTitle=狼疮性肾炎：已启动Itolizumab治疗狼疮性肾炎的Ib期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1d1180389f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387366, encodeId=2a89138e366ee, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=2019 EULAR/ACR标准：系统性红斑狼疮的分类标准, objectType=article, longId=180338, objectId=2cbb18033820, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2cbb18033820, replyNumber=0, likeNumber=10, createdTime=2019-10-02, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2cbb18033820, moduleTitle=2019 EULAR/ACR标准：系统性红斑狼疮的分类标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2cbb18033820)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387365, encodeId=6cbd138e36515, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=李学旺教授：狼疮性肾炎的预后影响因素与治疗策略丨CSN2019, objectType=article, longId=179892, objectId=f62b1e989281, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f62b1e989281, replyNumber=0, likeNumber=74, createdTime=2019-09-24, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f62b1e989281, moduleTitle=李学旺教授：狼疮性肾炎的预后影响因素与治疗策略丨CSN2019, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f62b1e989281)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387364, encodeId=f045138e36425, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=章海涛教授：难治性狼疮肾炎的治疗丨CSN2019, objectType=article, longId=179820, objectId=d23c1e98202e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d23c1e98202e, replyNumber=0, likeNumber=64, createdTime=2019-09-23, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d23c1e98202e, moduleTitle=章海涛教授：难治性狼疮肾炎的治疗丨CSN2019, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d23c1e98202e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387363, encodeId=6dbb138e3631e, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定, objectType=article, longId=179673, objectId=1fca1e96732d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fca1e96732d, replyNumber=0, likeNumber=53, createdTime=2019-09-20, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fca1e96732d, moduleTitle=FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1fca1e96732d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387362, encodeId=37a8138e36298, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=以 HELLP 综合征首发的系统性红斑狼疮1 例, objectType=article, longId=179512, objectId=17691e9512de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17691e9512de, replyNumber=0, likeNumber=120, createdTime=2019-09-17, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17691e9512de, moduleTitle=以 HELLP 综合征首发的系统性红斑狼疮1 例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17691e9512de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387361, encodeId=3193138e36187, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=Lancet Rheumato：系统性红斑狼疮临床治疗终点的确定, objectType=article, longId=179202, objectId=dcbf1e9202ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcbf1e9202ec, replyNumber=0, likeNumber=77, createdTime=2019-09-11, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcbf1e9202ec, moduleTitle=Lancet Rheumato：系统性红斑狼疮临床治疗终点的确定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcbf1e9202ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387360, encodeId=007e138e360b5, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=第二次TULIP临床试验使阿斯利康的狼疮药物——干扰素阻滞剂anifrolumab复活, objectType=article, longId=178695, objectId=31bd1e8695c9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=31bd1e8695c9, replyNumber=0, likeNumber=53, createdTime=2019-09-04, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=31bd1e8695c9, moduleTitle=第二次TULIP临床试验使阿斯利康的狼疮药物——干扰素阻滞剂anifrolumab复活, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=31bd1e8695c9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387359, encodeId=fcec138e3598e, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=J Rheumatol：创建虚弱指数作为系统性红斑狼疮的新型健康指标, objectType=article, longId=178317, objectId=f4d81e831722, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4d81e831722, replyNumber=0, likeNumber=60, createdTime=2019-08-30, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4d81e831722, moduleTitle=J Rheumatol：创建虚弱指数作为系统性红斑狼疮的新型健康指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4d81e831722)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387358, encodeId=de72138e358d3, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=Arthritis Rheumatol：系统性红斑狼疮中的周围神经系统疾病, objectType=article, longId=178229, objectId=ae1f1e8229ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae1f1e8229ae, replyNumber=0, likeNumber=60, createdTime=2019-08-28, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae1f1e8229ae, moduleTitle=Arthritis Rheumatol：系统性红斑狼疮中的周围神经系统疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae1f1e8229ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387357, encodeId=d3e6138e35707, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=狼疮性肾炎需及时治疗，免疫抑制剂必不可少, objectType=article, longId=176420, objectId=17b01e642030, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17b01e642030, replyNumber=0, likeNumber=70, createdTime=2019-07-31, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17b01e642030, moduleTitle=狼疮性肾炎需及时治疗，免疫抑制剂必不可少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17b01e642030)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387356, encodeId=6dfe138e3567d, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=青蒿素衍生物红斑狼疮候选新药进入II期临床, objectType=article, longId=175547, objectId=fa791e55472f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa791e55472f, replyNumber=0, likeNumber=68, createdTime=2019-07-17, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa791e55472f, moduleTitle=青蒿素衍生物红斑狼疮候选新药进入II期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa791e55472f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387355, encodeId=9b8a138e3550d, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=Ann Intern Med：系统性红斑狼疮患者孕产妇和胎儿结局趋势, objectType=article, longId=175457, objectId=d0bf1e545781, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0bf1e545781, replyNumber=0, likeNumber=178, createdTime=2019-07-16, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0bf1e545781, moduleTitle=Ann Intern Med：系统性红斑狼疮患者孕产妇和胎儿结局趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0bf1e545781)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387354, encodeId=eece138e354be, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=Clin Exp Rheumatol：狼疮性肾炎重复活检肾间质损伤加重的相关因素, objectType=article, longId=174539, objectId=86201e4539a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86201e4539a4, replyNumber=0, likeNumber=72, createdTime=2019-07-02, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86201e4539a4, moduleTitle=Clin Exp Rheumatol：狼疮性肾炎重复活检肾间质损伤加重的相关因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86201e4539a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387353, encodeId=a7de138e353f7, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=J Rheumatol：系统性红斑狼疮的疲劳指标, objectType=article, longId=174498, objectId=d97e1e449888, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d97e1e449888, replyNumber=0, likeNumber=66, createdTime=2019-07-01, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d97e1e449888, moduleTitle=J Rheumatol：系统性红斑狼疮的疲劳指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d97e1e449888)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387352, encodeId=717f138e352cf, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=J Rheumatol：系统性红斑狼疮的血压变异性和年龄相关血压模式, objectType=article, longId=172160, objectId=f56f1e2160af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f56f1e2160af, replyNumber=0, likeNumber=63, createdTime=2019-06-27, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f56f1e2160af, moduleTitle=J Rheumatol：系统性红斑狼疮的血压变异性和年龄相关血压模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f56f1e2160af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387351, encodeId=66bc138e351c7, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=上海仁济医院：雷帕霉素或成红斑狼疮潜在有效治疗药物, objectType=article, longId=168259, objectId=eaa316825915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eaa316825915, replyNumber=0, likeNumber=110, createdTime=2019-06-14, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eaa316825915, moduleTitle=上海仁济医院：雷帕霉素或成红斑狼疮潜在有效治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eaa316825915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387350, encodeId=2db9138e35047, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=IJLH：低、高狼疮抗凝血敏感性的配对APTTs可区分其他异常，并与dRVVT联合应用可获得良好的狼疮抗凝血检出率, objectType=article, longId=167539, objectId=a7de16e5393f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7de16e5393f, replyNumber=0, likeNumber=83, createdTime=2019-06-04, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7de16e5393f, moduleTitle=IJLH：低、高狼疮抗凝血敏感性的配对APTTs可区分其他异常，并与dRVVT联合应用可获得良好的狼疮抗凝血检出率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7de16e5393f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1387349, encodeId=5358138e34916, content=<a href='/topic/show?id=8a3a6814425' target=_blank style='color:#2F92EE;'>#狼疮#</a>, objectTitle=可遇不可求的狼疮细胞, objectType=article, longId=167436, objectId=77fb16e4364b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77fb16e4364b, replyNumber=0, likeNumber=89, createdTime=2019-06-02, rootId=0, userName=sunrural_42825357, userId=7a6e2500005, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77fb16e4364b, moduleTitle=可遇不可求的狼疮细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77fb16e4364b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

狼疮

2020-05-29

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

葛兰素史克的狼疮药物Benlysta在欧洲获得适应症扩容

2019-11-01

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

狼疮性肾炎：已启动Itolizumab治疗狼疮性肾炎的Ib期临床试验

2019-10-04

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

2019 EULAR/ACR标准：系统性红斑狼疮的分类标准

2019-10-02

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

李学旺教授：狼疮性肾炎的预后影响因素与治疗策略丨CSN2019

2019-09-24

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

章海涛教授：难治性狼疮肾炎的治疗丨CSN2019

2019-09-23

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

FDA授予罗氏的CD20单抗Gazyva在狼疮性肾炎中的突破性治疗指定

2019-09-20

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

以 HELLP 综合征首发的系统性红斑狼疮1 例

2019-09-17

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

Lancet Rheumato：系统性红斑狼疮临床治疗终点的确定

2019-09-11

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

第二次TULIP临床试验使阿斯利康的狼疮药物——干扰素阻滞剂anifrolumab复活

2019-09-04

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

J Rheumatol：创建虚弱指数作为系统性红斑狼疮的新型健康指标

2019-08-30

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

Arthritis Rheumatol：系统性红斑狼疮中的周围神经系统疾病

2019-08-28

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

狼疮性肾炎需及时治疗，免疫抑制剂必不可少

2019-07-31

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

青蒿素衍生物红斑狼疮候选新药进入II期临床

2019-07-17

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

Ann Intern Med：系统性红斑狼疮患者孕产妇和胎儿结局趋势

2019-07-16

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

Clin Exp Rheumatol：狼疮性肾炎重复活检肾间质损伤加重的相关因素

2019-07-02

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

J Rheumatol：系统性红斑狼疮的疲劳指标

2019-07-01

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

J Rheumatol：系统性红斑狼疮的血压变异性和年龄相关血压模式

2019-06-27

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

上海仁济医院：雷帕霉素或成红斑狼疮潜在有效治疗药物

2019-06-14

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

IJLH：低、高狼疮抗凝血敏感性的配对APTTs可区分其他异常，并与dRVVT联合应用可获得良好的狼疮抗凝血检出率

2019-06-04

sunrural_42825357 (审核中...)

前往app查看评论内容

#狼疮#

可遇不可求的狼疮细胞

2019-06-02

科室
- - 订阅+
  - 更多科室
工具
服务